Viatris
Rob O'Neill serves as the Regional Chief Financial Officer for North America at Viatris, overseeing strategic planning, budgeting, analytics, and financial reporting for U.S. subsidiaries since July 2021. Previously, O'Neill held various senior leadership roles at Mylan, including SVP of Global Commercial Excellence, where responsibility encompassed P&L ownership and global product launches, and SVP of Global Marketing and Sales Operations. O'Neill's extensive career includes significant financial roles at KV Pharmaceutical, Teva Pharmaceuticals USA, Orchid Cellmark, Cardinal Health, and The Clorox Company. O'Neill holds an Executive MBA from Villanova University and a BS in Business Administration with a focus on Accounting from Bryant University.
This person is not in any teams
Viatris
42 followers
Viatris is a new kind of global healthcare company formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer. By integrating the strengths of these two companies, including a global workforce of approximately ~45,000, Viatris aims to deliver increased access to affordable, quality medicines for patients worldwide, regardless of geography or circumstance.